Polyoxidonium Tablets 12 mg, # 10

Polyoxidonium tab.

12mg No. 10

Name ENG

POLYOXIDONIUM

Clinical and pharmacological group

Immunomodulator

ATX code

Immunostimulants

Dosage

12mg

Structure

Active ingredient: Azoximer bromide - 12 mg Excipients: mannitol - 3.6 mg, povidone K 17 - 2.4 mg, lactose monohydrate - 185.0 mg, potato starch - 45.0 mg, stearic acid - 2.0 mg.

...

Indications

It is used in adults and children from 3 years old for the treatment and prevention of acute and chronic respiratory diseases in the stage of exacerbation and remission.

For treatment (in combination therapy):

acute and exacerbation of chronic recurrent infectious and inflammatory diseases of the oropharynx, paranasal sinuses, upper and lower respiratory tract, inner and middle ear

allergic diseases (including hay fever, bronchial asthma), complicated by recurrent bacterial, fungal and viral infections

For prevention (monotherapy):

recurrent herpes infection of the nasal and labial region

exacerbations of chronic foci of infections of the oropharynx, paranasal sinuses, upper respiratory tract, inner and middle ear

secondary immunodeficiency states arising from aging or exposure to adverse factors.

Contraindications

Increased individual sensitivity

pregnancy, breastfeeding period

children under 3 years old

acute renal failure

rare hereditary lactose intolerance, lactase deficiency, glucose-galactose malabsorption syndrome.

Carefully:

If you have any of the conditions listed in this section, consult your doctor before taking this medicine:

- chronic renal failure (used no more than 2 times a week).

INN / Active ingredient

Azoximer bromide

Storage conditions and periods

At a temperature of 2-25 degrees.

Expiration date: 2 years

Specifications

Category

Antiviral

,

Antimicrobial agents

Scope of the medicinal product

Ear, Throat, Nose

,

Respiratory system

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

ten

Scope of application

Otorhinolaryngology

Minimum age from

3 years old

Way of introduction

Under the tongue

Vacation conditions

Without recipe

Brand name

Petrovax Pharm NPO LLC

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Immunomodulatory agent

Anatomical and therapeutic characteristics

L03 Immunostimulants

Dosage form

Pills

Packaging

Box

The target audience

Children

Dosage (volume) of the substance in the preparation

1 tablet: azoximer bromide 12 mg

Expiration date in days

730

Package weight, g

ten

Mode of application

:

Orally and sublingually 20-30 minutes before meals every day 2 times a day: children over 10 years old and adults - 1 tablet, children from 3 to 10 years old - by? tablets (6 mg). < br> If necessary, it is possible to carry out repeated courses of therapy in 3-4 months. When the drug is administered again, its effectiveness does not decrease. < br> Recommended treatment regimens < br> Sublingual < br> For treatment for adults: < br> Influenza and acute respiratory infections - 1 tablet 2 times a day for 7 days < br> Inflammatory processes of the oropharynx - 1 tablet 2 times per day for 10 days < br> exacerbations of chronic diseases of the upper respiratory tract, paranasal sinuses, chronic otitis media - 1 tablet 2 times a day for 10 days < br> allergic diseases (including hay fever, bronchial asthma),complicated by recurrent bacterial, fungal and viral infections - 1 tablet 2 times a day for 10 days. < br> For the treatment of children from 3 to 10 years old: < br> influenza and acute respiratory infections - by? tablets 2 times a day for 7 days < br> inflammatory processes of the oropharynx - by? tablets 2 times a day for 7 days < br> allergic diseases (including hay fever, bronchial asthma), complicated by recurrent bacterial, fungal and viral infections - according to? tablets 2 times a day for 7 days. < br> For the treatment of children over 10 years old: < br> influenza and acute respiratory infections - 1 tablet 2 times a day for 7 days < br> inflammatory processes of the oropharynx - 1 tablet 2 times a day for 7 days < br> exacerbations of chronic diseases of the upper respiratory tract,paranasal sinuses, chronic otitis media - 1 tablet 2 times a day for 7 days < br> allergic diseases (including hay fever, bronchial asthma), complicated by recurrent bacterial, fungal and viral infections - 1 tablet 2 times a day for 7 days. < br> For prophylaxis for adults: < br> influenza and acute respiratory infections in the pre-epidemic period - 1 tablet a day for 10 days < br> recurrent herpes infection of the nasal and labial region - 1 tablet 2 times a day for 10 days < br> exacerbations of chronic foci of infections of the oropharynx, paranasal sinuses, upper respiratory tract, inner and middle ear - 1 tablet once a day for 10 days < br> secondary immunodeficiency,arising from aging or exposure to adverse factors - 1 tablet 1 time per day for 10 days. < br> For the prevention of children from 3 to 10 years old: < br> influenza and acute respiratory infections in the pre-epidemic period - by? tablets per day for 7 days < br> recurrent herpes infection of the nasal and labial region - by? tablets 2 times a day for 7 days < br> exacerbations of chronic foci of infections of the oropharynx, paranasal sinuses, upper respiratory tract, inner and middle ear - by? tablets once a day for 10 days. < br> For the prevention of children over 10 years of age: < br> influenza and acute respiratory infections in the pre-epidemic period - 1 tablet a day for 7 days < br> recurrent herpes infection of nasal and labial area - 1 tablet 2 times a day for 7 days < br> exacerbations of chronic foci of infections of the oropharynx, paranasal sinuses, upper respiratory tract, inner and middle ear, 1 tablet once a day for 10 days. < br> Oral < br> For the treatment of adults: < br> diseases of the upper and lower respiratory tract - 1 tablet 2 times 10 days. < br> For the treatment of children over 10 years old: < br> diseases of the upper and lower respiratory tract - 1 tablet 2 times 10 days < br> < br> diseases of the upper and lower respiratory tract - 1 tablet 2 times 10 days < br> < br> diseases of the upper and lower respiratory tract - 1 tablet 2 times 10 days < br> < br>

Information on technical characteristics, delivery set, country of manufacture